In a recent video interview published by Le Quotidien du Médecin, Dr. Clément Gakuba (CHU Caen) highlights how our SYLVER ultrasound device enables advanced brain perfusion imaging directly at the patient’s bedside. The technology was evaluated in a first clinical study involving 15 patients with subarachnoid hemorrhage, demonstrating both feasibility and the ability to identify different perfusion profiles.

La start-up, issue du spin-off d’un laboratoire, vient de réaliser sa première levée de fonds de 2,2 millions d’euros. Elle va lancer ses essais cliniques avec le CHU de Caen à la fin de l’année.

A long-term investment plan is helping the French capital to attract talent.

High-resolution imaging quickly identifies blood clots before they inflict major damage. Resolve Stroke in Paris spin off from Sorbonne University…